Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78.4M
-
Number of holders
-
56
-
Total 13F shares, excl. options
-
22.2M
-
Shares change
-
+150K
-
Total reported value, excl. options
-
$221M
-
Value change
-
-$471K
-
Number of buys
-
27
-
Number of sells
-
-28
-
Price
-
$9.97
Significant Holders of Replimune Group, Inc. - COMMON STOCK (REPL) as of Q1 2020
65 filings reported holding REPL - Replimune Group, Inc. - COMMON STOCK as of Q1 2020.
Replimune Group, Inc. - COMMON STOCK (REPL) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.2M shares
of 78.4M outstanding shares and own 28.29% of the company stock.
Largest 10 shareholders include Omega Fund Management, LLC (5.32M shares), Redmile Group, LLC (2.98M shares), Bain Capital Life Sciences Investors, LLC (2.84M shares), BVF INC/IL (1.98M shares), BlackRock Inc. (1.04M shares), FMR LLC (890K shares), EMERALD ADVISERS, LLC (796K shares), EMERALD MUTUAL FUND ADVISERS TRUST (779K shares), VANGUARD GROUP INC (772K shares), and Artal Group S.A. (600K shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.